EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
JG Paez, PA Janne, JC Lee, S Tracy, H Greulich… - Science, 2004 - science.org
… gefitinib revealed no survival benefit for the gefitinib-treated … that gefitinib may be particularly
effective for treating lung … EGFR mutations and that prospective clinical trials of EGFR …
effective for treating lung … EGFR mutations and that prospective clinical trials of EGFR …
EGFR mutation and response of lung cancer to gefitinib
S Toyooka, K Kiura, T Mitsudomi - N Engl J Med, 2005 - researchgate.net
… mutations. In addition, detecting T790M may be useful for predicting pretreatment resistance
to EGFR … help clarify the role of EGFR mutations in the development of EGFR-related non–…
to EGFR … help clarify the role of EGFR mutations in the development of EGFR-related non–…
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
JY Wu, SG Wu, CH Yang, YL Chang, YC Chang… - Lung cancer, 2011 - Elsevier
… and gefitinib are tyrosine kinase (TK) inhibitors of epidermal growth factor receptor (EGFR)
that are effective in treating … to compare their clinical uses and the influence of EGFR mutation. …
that are effective in treating … to compare their clinical uses and the influence of EGFR mutation. …
[HTML][HTML] … of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non‑small cell lung cancer in patients with common and rare EGFR gene mutations
P Krawczyk, DM Kowalski, R Ramlau… - Oncology …, 2017 - spandidos-publications.com
… Our study confirms results indicating that rare EGFR mutations are important for EGFR-TKIs
treatment outcomes (21). However, further research is required to build a database of all …
treatment outcomes (21). However, further research is required to build a database of all …
FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation–Positive Non–Small Cell Lung Cancer
D Kazandjian, GM Blumenthal, W Yuan, K He… - Clinical Cancer …, 2016 - AACR
… Patients with known acquired or intrinsic EGFR resistance mutations (T790M and exon …
gefitinib treatment. Table 1 depicts the benefit–risk framework for gefitinib in the EGFR mutation–…
gefitinib treatment. Table 1 depicts the benefit–risk framework for gefitinib in the EGFR mutation–…
EGFR mutations in patients with brain metastases from lung cancer: Association with the efficacy of gefitinib
S Shimato, T Mitsudomi, T Kosaka, Y Yatabe… - Neuro …, 2006 - academic.oup.com
… brain metastases during gefitinib treatment, evaluated the efficacy of gefitinib, and examined
the association between this efficacy of gefitinib in brain metastases and EGFR mutations. …
the association between this efficacy of gefitinib in brain metastases and EGFR mutations. …
[HTML][HTML] The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer
XT Zhang, LY Li, XL Mu, QC Cui, XY Chang, W Song… - Annals of oncology, 2005 - Elsevier
… The efficacy of gefitinib has been explored extensively in the West and in Japan. We aimed
… activity of gefitinib as well as the relationship between response and EGFR mutation in a …
… activity of gefitinib as well as the relationship between response and EGFR mutation in a …
[HTML][HTML] Effectiveness of gefitinib against non–small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q
S Watanabe, Y Minegishi, H Yoshizawa… - Journal of thoracic …, 2014 - Elsevier
… of gefitinib in NSCLC patients with uncommon EGFR mutations, we analyzed the data of 114
patients in the gefitinib … advance the treatment of NSCLC with uncommon EGFR mutations. …
patients in the gefitinib … advance the treatment of NSCLC with uncommon EGFR mutations. …
Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous …
N Sunaga, Y Tomizawa, N Yanagitani, H Iijima, K Kaira… - Lung Cancer, 2007 - Elsevier
… effectiveness of gefitinib in chemotherapy-naïve NSCLC patients with EGFR mutations [29],
[… not received chemotherapy prior to gefitinib treatment responded to gefitinib (CR: two cases; …
[… not received chemotherapy prior to gefitinib treatment responded to gefitinib (CR: two cases; …
[HTML][HTML] EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
… Here we report the case of a patient with EGFR-mutant, gefitinib-responsive, advanced non–…
complete remission during treatment with gefitinib. The DNA sequence of the EGFR gene in …
complete remission during treatment with gefitinib. The DNA sequence of the EGFR gene in …
相关搜索
- cell lung cancer egfr mutations
- efficacy of gefitinib egfr mutations
- gefitinib and erlotinib egfr mutations
- egfr mutation status
- pooled analysis egfr mutations
- brain metastases egfr mutations
- gefitinib therapy egfr mutations
- first line gefitinib egfr mutations
- lung adenocarcinoma egfr mutations
- egfr mutation previously treated chinese patients
- optimal treatment egfr mutations
- non-adenocarcinoma nsclc patients with egfr mutation
- gefitinib treatment in patients
- epidermal growth factor receptor egfr mutations
- clinical outcomes egfr mutations
- gefitinib in nsclc patients egfr mutations